Researchers at Imperial College London and the Royal Brompton Hospital are recruiting patients into a research study with a diagnosis of dilated cardiomyopathy, whose heart function remains impaired despite usual therapy.
Image
They want to see if a new antioxidant therapy called MitQ may help promote recovery in heart function by improving the function of mitochondria, the energy producing centres in patients’ hearts. For more information on this study and how to take part click here